Maßvolle Substantiierungsanforderungen im Produkthaftungsprozess über risikobehaftete Medizinprodukte
Crossref DOI link: https://doi.org/10.1007/s00350-021-6010-z
Published Online: 2021-10-07
Published Print: 2021-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Text and Data Mining valid from 2021-10-01
Version of Record valid from 2021-10-01
Article History
First Online: 7 October 2021